EKU Podcast: The evolving role of GLP1-RA in obesity

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of drugs initially developed to treat type 2 diabetes and are now becoming more widely used for obesity. They work by mimicking the actions of the GLP-1 hormone, which is released by the gut after eating. GPs will be used to prescribing them for type 2 diabetes, but less so for obesity. In this podcast, Dr Thomas Round discusses the evolving role of GLP1-RA in obesity, the benefits and potential side effects, the role of the GP, and the latest NICE guidance in this area with Dr Stephanie DiGiorgio, an urgent care GP with a specialist interest in obesity. This podcast falls within the Metabolic Problems and Endocrinology curriculum field.

You can listen to EKU Podcast: The evolving role of GLP1-RA in obesity online on Radio and Podcast. Open the player on this page to stream the available audio.

EKU Podcast: The evolving role of GLP1-RA in obesity is an episode from RCGP eLearning Podcast.

This episode is 21:26 long.

This episode was published on Feb 6, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from RCGP eLearning Podcast when more episodes are available from the podcast feed.